LeadIQ logo
Learn more at LeadIQ.com

Insights

Loading spinner
Gathering insights about EvolveImmune Therapeutics

Similar companies to EvolveImmune Therapeutics

EvolveImmune Therapeutics Tech Stack

EvolveImmune Therapeutics uses 8 technology products and services including Google Analytics, WP Rocket, Squarespace, and more. Explore EvolveImmune Therapeutics's tech stack below.

  • Google Analytics
    Analytics
  • WP Rocket
    Caching
  • Squarespace
    Content Management System
  • WordPress
    Content Management System
  • Shopify
    E-commerce
  • BugHerd
    Issue Trackers
  • Modernizr
    Javascript Libraries
  • Smartsheet
    Project Management

Media & News

EvolveImmune Therapeutics's Email Address Formats

EvolveImmune Therapeutics uses at least 1 format(s):
EvolveImmune Therapeutics Email FormatsExamplePercentage
First.Last@evolveimmune.comJohn.Doe@evolveimmune.com
92%
Last@evolveimmune.comDoe@evolveimmune.com
4%
First_Last@evolveimmune.comJohn_Doe@evolveimmune.com
2%
LFirst@evolveimmune.comDJohn@evolveimmune.com
2%

Frequently Asked Questions

Where is EvolveImmune Therapeutics's headquarters located?

Minus sign iconPlus sign icon
EvolveImmune Therapeutics's main headquarters is located at Branford, CT US. The company has employees across 1 continents, including North America.

What is EvolveImmune Therapeutics's official website and social media links?

Minus sign iconPlus sign icon
EvolveImmune Therapeutics's official website is evolveimmune.com and has social profiles on LinkedIn.

How much revenue does EvolveImmune Therapeutics generate?

Minus sign iconPlus sign icon
As of November 2024, EvolveImmune Therapeutics's annual revenue reached $3.8M.

What is EvolveImmune Therapeutics's SIC code NAICS code?

Minus sign iconPlus sign icon
EvolveImmune Therapeutics's SIC code is 8733 - Noncommercial Research Organizations NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).

How many employees does EvolveImmune Therapeutics have currently?

Minus sign iconPlus sign icon
As of November 2024, EvolveImmune Therapeutics has approximately 41 employees across 1 continents, including North America. Key team members include Chief Executive Officer: S. B.Chief Financial Officer: J. G.Chief Business Officer: M. F.. Explore EvolveImmune Therapeutics's employee directory with LeadIQ.

What industry does EvolveImmune Therapeutics belong to?

Minus sign iconPlus sign icon
EvolveImmune Therapeutics operates in the Biotechnology Research industry.

What technology does EvolveImmune Therapeutics use?

Minus sign iconPlus sign icon
EvolveImmune Therapeutics's tech stack includes Google AnalyticsWP RocketSquarespaceWordPressShopifyBugHerdModernizrSmartsheet.

What is EvolveImmune Therapeutics's email format?

Minus sign iconPlus sign icon
EvolveImmune Therapeutics's email format typically follows the pattern of . Find more EvolveImmune Therapeutics email formats with LeadIQ.

How much funding has EvolveImmune Therapeutics raised to date?

Minus sign iconPlus sign icon
As of November 2024, EvolveImmune Therapeutics has raised $20M in funding. The last funding round occurred on Oct 29, 2024 for $20M.

When was EvolveImmune Therapeutics founded?

Minus sign iconPlus sign icon
EvolveImmune Therapeutics was founded in 2020.
EvolveImmune Therapeutics

EvolveImmune Therapeutics

Biotechnology ResearchConnecticut, United States11-50 Employees

At EvolveImmune, we harness our “Immunology First” approach to create first-in-category cancer medicines to transform the lives of patients by delivering superior, long-term outcomes compared to current anti-cancer therapies.

We are pioneers who rapidly translate discoveries into innovations and innovations into differentiated therapeutic solutions, to address the most significant unmet medical needs in oncology.

We are based in Branford, CT and Farmington, CT.

Section iconCompany Overview

Headquarters
Branford, CT US
SIC Code
8733 - Noncommercial Research Organizations
NAICS Code
541714 - Research and Development in Biotechnology (except Nanobiotechnology)
Founded
2020
Employees
11-50

Section iconFunding & Financials

  • $20M

    EvolveImmune Therapeutics has raised a total of $20M of funding over 3 rounds. Their latest funding round was raised on Oct 29, 2024 in the amount of $20M.

  • $10M

    EvolveImmune Therapeutics's revenue is in the range of $10M

Section iconFunding & Financials

  • $20M

    EvolveImmune Therapeutics has raised a total of $20M of funding over 3 rounds. Their latest funding round was raised on Oct 29, 2024 in the amount of $20M.

  • $10M

    EvolveImmune Therapeutics's revenue is in the range of $10M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.